Torrent Pharmaceuticals Limited

NSE TORNTPHARM.NS

Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2024: 44.09%

Torrent Pharmaceuticals Limited Gross Profit Margin is 44.09% for the year ending March 31, 2024, a -37.99% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2023 was 71.10%, a 1.78% change year over year.
  • Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2022 was 69.86%, a -2.51% change year over year.
  • Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2021 was 71.66%, a 0.86% change year over year.
  • Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2020 was 71.05%, a 3.14% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
NSE: TORNTPHARM.NS

Torrent Pharmaceuticals Limited

CEO Mr. Sanjay Gupta
IPO Date July 1, 2002
Location India
Headquarters Torrent House
Employees 15,718
Sector Health Care
Industries
Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies
Description

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Similar companies

APOLLOHOSP.NS

Apollo Hospitals Enterprise Limited

USD 77.49

-1.80%

AJANTPHARM.NS

Ajanta Pharma Limited

USD 32.53

1.58%

AUROPHARMA.NS

Aurobindo Pharma Limited

USD 13.57

1.28%

ALKEM.NS

Alkem Laboratories Limited

USD 60.83

0.86%

TORNTPOWER.NS

Torrent Power Limited

USD 15.92

5.37%

StockViz Staff

January 15, 2025

Any question? Send us an email